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| INTRODUC TI ON
Parkinson's disease (PD) is a common neurodegenerative disease prevalent in older persons. It is characterized by the progressive loss of dopamine (DA) neurons in the substantia nigra pars compacta and the striatal DA deficiency. 1 Current therapies for PD are mainly aimed at ameliorating motor symptoms associated with DA deficiency, including levodopa, DA agonists, catechol-O-methyltransferase inhibitors, and monoamine oxidase-B inhibitors. 2, 3 However, these therapies do not slow down disease progression and their efficacy decline over time, accompanied by severe side effects such as dyskinesia and on-off fluctuation. 4, 5 A significant progress has been made in cell therapy for PD treatment in the last 30 years, with the grafted cell sources from fetal tissue to induced pluripotent stem cells. 6 Neural stem cells (NSCs) are considered to be the most promising source of transplanted cells due to their self-renewing and multipotent characteristics. 7 However, some issues still exist. One concern is that most in vivo transplanted NSCs are differentiated into glial cells rather than neurons. Another challenge is that only 5%-10% of the NSCs survive after transplantation due to the toxic effect of the inflammatory environment. 8 Previous studies have shown that the microglia activation and the associated inflammatory changes are considered as major pathogenic contributors to PD. [9] [10] [11] Microglia can produce both pro-inflammatory and neurotrophic cytokines in the central nervous system. 12, 13 Therefore, a strategy biased toward beneficial microglia could be a promising therapeutic approach in PD.
Nuclear receptor-related factor 1 (Nurr1, also known as NR4A2)
is an orphan nuclear receptor initially characterized as a transcription factor, which is critical for the development, differentiation, maintenance, and survival of DA neurons in the midbrain. 14 A reduction in the expression of Nurr1 in adult mice leads to a progressive loss of mDA neurons. 14 Conversely, overexpression of Nurr1 using a viral vector protects dopaminergic neurons against α-synuclein toxicity by restoring glial cell-derived neurotrophic factor (GDNF) levels. 15 In addition, Saijo et al 16 showed that Nurr1 could inhibit the expression of pro-inflammatory mediators in both microglia and astrocytes. The reduced expression of Nurr1 increases the vulnerability to inflammation-induced DA neuron death.
Taken together, new strategies that target intrinsic pathways modifying the disease environment surrounding mDA neurons are required to treat PD. In this study, NSCs and microglia were both transfected with lentiviral vector overexpression of Nurr1, before being transplanted into the striatum of PD model rats. The results suggested that the overexpression of Nurr1 improved the behavioral deficits of PD rats and increased the level of striatal DA neurons by promoting the differentiation of NSCs into dopaminergic neurons and modulating toxic environments surrounding these neurons. 
| MATERIAL S AND ME THODS

| Animals
| Neural stem cell culture
The ventral mesencephalic neural tissue was harvested from fetal Sprague Dawley rats on embryonic days 12.5-14.5 (E12.5-14.5) under sterile conditions. The ventral mesencephalic neural stem cells (mNSCs) were isolated, expanded, and detected according to a method described previously. 17 Briefly, mNSCs were cultured in serum-free DMEM/F12 medium containing 2% B27 (Gibco)
supplemented with the mitogen basic fibroblast growth factor (bFGF; 20 ng/mL; PeproTech, USA) and epidermal growth factor (EGF; 20 ng/mL; PeproTech).
| Microglia cultures
Primary cultures for mixed astrocytes and microglia were derived from the cerebrum of SD rat pups on postnatal day 1 (PN1) using the protocol previously described. 18 Briefly, the cerebrum was removed and minced, and the cells were cultured in DMEM/high glucose containing 10% fetal bovine serum (FBS; HyClone, China). The cells were plated in 75-cm 2 T-flasks. The microglia were harvested by gentle shaking and collected for further use 12-14 days after initial seeding.
| Lentiviral construction
Lentiviral vectors expressing Nurr1 under the control of the CMV promoter were generated by inserting Nurr1 cDNA into the mul- 
| Transplantation procedure and behavior test
Before transplantation, the neurospheres and microglia were har- Behavioral testing was carried out 3, 6, 9, and 12 weeks after transplantation. APO (Sigma) was subcutaneously injected at a dose of 0.25 mg/kg, and rotation was monitored for 30 minutes.
| Immunohistochemistry
After 12 weeks of surgery, the rats from each group were per- 
| Western blot analysis
After 12 The membranes were washed with TBST and incubated with the goat anti-rabbit horseradish peroxidase secondary antibody (1:1000; Millipore) for 2 hours at room temperature. Proteins were detected using the enhanced chemiluminescent reagent (Millipore). The relative levels of immunoreactivity protein were quantified using ImageJ software (NIH), and data were normalized to β-actin before statistical analysis.
| Reverse transcription polymerase chain reaction
Total RNA was extracted from tissues (n = 4 per group) using TRIzolUniversal reagent (Tiangen Biotech) and used for complementary DNA (cDNA) synthesis. Nurr1, TH, Pitx3, DAT, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; control) cDNA fragments were amplified using the following primers: Nurr1
and GAPDH (forward 5′-TGCCTCCTGCACCACCAACT -3′, reverse 5′-CCCGTTCAGCTCAGGGATGA -3′). All transcripts were amplified by initial denaturation at 94°C for 3 minutes, 35 cycles of 94°C for 45 seconds, 58°C for 45 seconds, and 72°C for 1 minute, and a final extension at 72°C for 10 minutes. The polymerase chain reaction (PCR) products were subjected to 1% agarose gel electrophoresis, and the abundance of each mRNA was normalized to GAPDH using ImageJ software (NIH).
| Cell counting and statistical analysis
Immunoreactive cells were counted in 10-20 random areas of each culture coverslip using an eyepiece grid at a final magnification of 400×. Data were expressed as mean ± standard error of the mean of three independent experiments. For every figure, statistical tests were justified as appropriate. Statistical comparisons were determined using one-way analysis of variance followed by Bonferroni post hoc analysis using SPSS (Statistics 21; IBM Inc). A P value <0.05 was considered significant.
| RE SULTS
| Identification of mNSCs and microglia in vitro
mNSCs were isolated from E12.5 to E14.5 rats as described. After 7 days of plating, neurospheres (150-200 µm) were formed, which were immunopositive for the stem cell marker nestin ( Figure 1A ).
Then, these neurospheres were collected by centrifugation, resuspended in neural stem cell differentiation medium (DMEM/ F12, 1% FBS), and cultured for 7 days on polylysine-coated coverslips. After 7 days in culture, the cells derived from NSCs were stained with antibodies against Tuj1 and glial fibrillary acidic protein ( Figure 1B and 1C) . In addition, TH immunoreactivity was detected in subpopulations of TuJ1+ neuronal cells ( Figure 1D ).
Importantly, these TH+ cells were considered as mature DA neurons, which were evidenced by the expression of DAT (DA transporter, Figure 1E ).
Primary microglia cells were isolated after 14 days of mixed glial cell culture. The resting form of microglia was composed of long branching processes and a small cellular body. The ramified microglia could be transformed into the reactive state form in response to lipopolysaccharide (LPS)-mediated inflammatory environment. These cells were immunoreactive for CD11b (95%; Figure 1F ).
| Nurr1 overexpression in NSCs and microglia
The Figure 3A-D) .
F I G U R E 2 Overexpression of Nurr1 in neural stem cells and microglia. (A and C) Green fluorescent protein and red fluorescent protein were detected in neurospheres and microglial cells 72 h after transfection by lentiviral vectors. (B and D)
Western blot analysis was performed to detect the effectiveness of transgene expression. Scale bar for A and C, 100 μm. **P < 0.01, ***P < 0.001 compared with the control group, unpaired Student's t-test. Western blot analysis and polymerase chain reaction (n = 3-4)
F I G U R E 3 Effects of Nurr1 overexpression on Neural stem cells and microglial cells. (A-D)
Western blot and reverse transcription polymerase chain reaction analyses were performed to detect the expression of TH and DAT 7 days after differentiation culture of neural stem cells. (E and F) Pro-inflammatory cytokines and neurotrophic factors were measured using enzyme-linked immunosorbent assay. *P < 0.01, **P < 0.01, ***P < 0.001 compared with the control group, unpaired Student's t-test (n = 3-5)
To examine the effect of Nurr1 in microglia activation, the microglia were divided into the following four groups: the control group was treated with PBS, the LPS group with LPS (100 ng/mL), the Nurr1 group with PBS 48 hours after transfection with Nurr1, and the LPS-Nurr1 group with LPS (100 ng/mL) 48 hours after transfection with Nurr1. The culture medium was collected, and the enzyme-linked immunosorbent assay was performed 24 hours after LPS (or PBS) treatment. Microglia over-expressed Nurr1 significantly elevated the expression of neurotrophic factors BDNF and GDNF ( Figure 3E ). Conversely, the results suggested that forced expression of Nurr1 in microglia led to a significant reduction in the expression of the pro-inflammatory cytokines, such as tumor necrosis factor-α(TNF-α) and interleukin-1β (IL-1β; Figure 3F ).
| Transplantation of NNSC + NMG reversed motor behavior deficits in PD rats
Based on the in vitro results, the study next examined whether NSCs and microglia both with Nurr1 overexpression could improve the rotational asymmetry in PD rats. The rotational response to amphetamine was examined 3, 6, 9, and 12 weeks after transplantation ( Figure 4 ). Animals grafted with NSC, NNSC, NNSC + MG, or NNSC + NMG showed recovery 3 weeks after surgery from amphetamine-induced turning behavior, whereas the control (sham group) animals did not. However, in the NSC group, the rotation number reached a plateau in around the sixth week and even increased after it. Importantly, the rotation behavior in the NNSCs + NMG group significantly improved as the rotation number decreased over time.
Three rats were sacrificed because of sickness before the endpoint of the study. 
| D ISCUSS I ON
Stem cell-based cell replacement is a highly promising therapeutic approach because the main pathology of PD is selective degeneration of mDA neurons in the SN. However, the efficient differentiation F I G U R E 4 Amphetamine-induced rotation scores were analysed after cell transplantation. Each value depicts mean ± SEM of percent change in the score compared with the pretransplantation value. *P < 0.01 vs the control group (sham group), #P < 0.05 vs the NSC group, ≠P < 0.05 vs the NNSC group, and △P < 0.05 vs the NNSC + MG group, one-way analysis of variance followed by Bonferroni post hoc test of DA neurons from grafted mNSCs is challenging. Importantly, the key obstacles to the success of preclinical trials in PD are the poor survival of grafted cells. 20 After cell transplantation, the hostile host brain environment is mainly responsible for unsatisfactory results.
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A few studies targeted the host brain to improve therapeutic effects. 22, 23 However, none of these studies used an inflammationbased therapy and microglia-NSC combined approach to modify the detrimental host brain environment. Furthermore, recent studies have shown that Nurr1-activating compounds, Nurr1 modulators, and
Nurr1-based cell transplantation have certain therapeutic effects on PD animal model. 15, [24] [25] [26] However, most of these studies ignored the interference of the hostile and inflammatory environments, which could seriously damage the outcome of these treatments. Based on these findings, it was presumed that the neurotrophic properties of microglia and Nurr1 can help in attaining an improvement in the therapeutic efficacy of cell transplantation in PD.
Nurr1 was initially characterized as a transcription factor that regulated the expression of the gene encoding TH. 27 It seemed to be expressed earlier than numerous phenotypic markers of DA neurons, such as TH, DAT, and vesicular monoamine transporter (VMAT). 28 Previous studies have demonstrated an important role of Nurr1 in both the differentiation of dopaminergic neurons in embryonic stages and the long-term maintenance of the dopaminergic phenotype throughout life. 29 Apart from that, several studies have indicated an anti-inflammatory role of Nurr1 in neuroinflammation, which is also considered a risk factor for the development of PD. 16, 30 As shown in Figures 2 and 3 F I G U R E 1 0 Schematic summary of the DA neuron survival and the neurotrophic effects of Nurr1-Microglia and neural stem cell co-grafted in PD treatment. Activated microglia produce pro-inflammatory cytokines that contribute to DA neurons death. Nurr1-overexpressed microglial cells co-grafted with Nurr1-overexpressed NSCs promote the survival of transplanted NSCs, and DA neuron differentiation. As result, the abnormal behaviors in PD rats are improved by correcting the inflammatory host brain environments change suggested that the outcomes in these experimental groups improved for the presence of Nurr1 overexpression. Furthermore, the increase in the expression levels of Pitx3, TH, DAT, and Nurr1 was further confirmed using RT-PCR and Western blot analyses ( Figure 6 ).
They were all DA neuron-related transcription factors, indicating that the number of DA neurons obviously increased in the NNSC + NMG group. Next, the present study used immunofluorescence to investigate whether forced expression of Nurr1 reduced the activation of microglia in the striatum of PD rats. The results showed that the expression level of Iba1+ cells in the NNSC + NMG group decreased 12
after transplantation compared with the other groups (Figures 7 and 8 ).
Moreover, this study found that most implanted cells were localized in the transplant area, and only a few of them were observed in the striatum of PD rats in the NNSC + NMG group after months ( Figure 9 ).
Based on the results and previous studies, the molecular mechanisms underlying the neuroprotective effects of Nurr1 on PD included the reduction of inflammatory factors and the secretion of neurotrophic factors and other cytokines, such as SHH and FGF8.
21,33
| CON CLUS ION
In conclusion, the aforementioned in vitro and in vivo findings demonstrated that the overexpression of Nurr1 promoted the differentiation of NSCs into DA neurons, increased the number of TH+ cells in the striatum, and reduced the number of Iba1+ cells, resulting in an improvement in the rotation behavior. Therefore, transplantation of Nurr1-overexpressing NSCs and microglia, which aims to improve the inhospitable host brain environments, has great potential for treating PD.
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